Cite
HARVARD Citation
Anjum, A. et al. (n.d.). E093 Real-life switching from infliximab innovator (Remicade) to biosimilar (Inflectra) in patients with various rheumatic diseases: a 6-month single-centre prospective observational study. Rheumatology. p. . [Online].